1. Home
  2. QXL vs CYPH Comparison

QXL vs CYPH Comparison

Compare QXL & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum X Labs Inc. Common Stock

QXL

Quantum X Labs Inc. Common Stock

N/A

Current Price

$5.03

Market Cap

75.6M

Sector

Technology

ML Signal

N/A

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.69

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QXL
CYPH
Founded
N/A
2011
Country
Israel
United States
Employees
21
6
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.6M
73.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
QXL
CYPH
Price
$5.03
$0.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
77.7K
1.5M
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.05
$0.49
52 Week High
$7.70
$3.70

Technical Indicators

Market Signals
Indicator
QXL
CYPH
Relative Strength Index (RSI) N/A 45.04
Support Level N/A $0.58
Resistance Level N/A $0.79
Average True Range (ATR) 0.00 0.05
MACD 0.00 0.00
Stochastic Oscillator 0.00 29.18

Price Performance

Historical Comparison
QXL
CYPH

About QXL Quantum X Labs Inc. Common Stock

Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: